Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 5:16 pm Sale | 2025-06-30 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Great Point Partners, LLC | 796,558 6.240% | -350,759 (-30.57%) | Filing History |
| 2025-08-14 5:15 pm Unchanged | 2025-06-30 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | Great Point Partners, LLC | 2,220,000 4.990% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:13 pm Unchanged | 2025-06-30 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Great Point Partners, LLC | 2,055,834 6.590% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:12 pm Unchanged | 2025-06-30 | 13G | PROMIS NEUROSCIENCES INC PMN | Great Point Partners, LLC | 133,381 9.990% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:11 pm Unchanged | 2025-06-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 4,683,711 5.220% | 0 (Unchanged) | Filing History |
| 2025-06-20 12:47 pm Purchase | 2025-05-05 | 13G | INVENTIVA SA ADR IVA | Great Point Partners, LLC | 10,576,827 7.420% | 10,576,827 (New Position) | Filing History |
| 2025-05-15 4:48 pm Unchanged | 2025-03-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Great Point Partners, LLC | 2,055,834 6.650% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:47 pm Unchanged | 2025-03-31 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | Great Point Partners, LLC | 2,220,000 6.370% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:45 pm Sale | 2025-03-31 | 13G | OPTINOSE INC OPTN | Great Point Partners, LLC | 526,315 4.940% | -370,270 (-41.30%) | Filing History |
| 2025-05-15 4:44 pm Unchanged | 2025-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 4,683,711 5.220% | 0 (Unchanged) | Filing History |
| 2025-05-14 4:11 pm Unchanged | 2025-05-08 | 13G | ZURA BIO LTD ZURA | Great Point Partners, LLC | 3,170,194 5.120% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:40 pm Sale | 2024-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Great Point Partners, LLC | 2,055,834 6.880% | -674,075 (-24.69%) | Filing History |
| 2025-02-14 4:39 pm Purchase | 2024-12-31 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Great Point Partners, LLC | 1,147,317 9.990% | 195,074 (+20.49%) | Filing History |
| 2025-02-14 4:39 pm Purchase | 2024-12-31 | 13G | PROMIS NEUROSCIENCES INC PMN | Great Point Partners, LLC | 133,381 9.990% | 13,094 (+10.89%) | Filing History |
| 2025-02-14 4:38 pm Sale | 2024-12-31 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | Great Point Partners, LLC | 2,220,000 8.180% | -261,973 (-10.56%) | Filing History |
| 2025-02-14 4:37 pm Sale | 2024-12-31 | 13G | OPTINOSE INC OPTN | Great Point Partners, LLC | 896,585 8.470% | -123,878 (-12.14%) | Filing History |
| 2025-02-14 4:33 pm Sale | 2024-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 4,683,711 6.250% | -2,251,271 (-32.46%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | ZURA BIO LTD ZURA | Great Point Partners, LLC | 3,170,194 4.860% | -93,478 (-2.86%) | Filing History |
| 2025-02-14 4:31 pm Sale | 2024-12-31 | 13G | NEUROGENE INC NGNE | Great Point Partners, LLC | 442,761 2.980% | -561,530 (-55.91%) | Filing History |
| 2024-11-14 5:06 pm Sale | 2024-09-30 | 13G | ZURA BIO LTD ZURA | Great Point Partners, LLC | 3,263,672 5.120% | -31,328 (-0.95%) | Filing History |